CEACAM8 and gastric cancer: Recently, Jiang et al. [42] developed immune‐based classification (Immunoscore), a prediction model for GC patients using CD3 IF, CD3 IT, CD8 IF, CD45RO IT, and CD66b IF data from 879 consecutive patients.